globeandmail.com
    globeandmail.com/globe-investor/portfolio-and-tools

RBC Life Science and Technology A
  Profiles Help     Click here to print this page

Fund Sponsor: RBC Global Asset Management Inc.
Portfolio Manager: RBC Global Asset Management Inc.
Fund Type: Open-Ended

Asset Class: U.S. Equity
5-Star Rating:
RRSP Eligible: Yes

Inception Date: July, 1995
Total Assets: $178.38Million  
Sales Fee Type: No Load
Mgmt Expense Ratio (MER): 2.20%
Closed: No

Min. Invest (initial): $500.00
Subsequent: $25.00
Min. Invest (initial RRSP): $500.00
Subsequent RRSP: $25.00
Restricted: No


Statistics


As of April 20, 2018

Current Price: $17.80
Daily Change $: -$0.08
1 day: -0.46%
7 day: 1.22%
Month-to-Date: 0.07%
30 day: -5.59%
Year-to-Date: 4.29%

Returns as of March 31, 2018
Fund Group Avg Index*
1 month -3.33% -1.77% -1.94%
3 month 4.21% 0.52% 2.12%
6 month 10.58% 6.60% 9.10%
1 year 16.24% 9.31% 10.20%
3 year 9.74% 7.42% 11.44%
5 year 21.43% 13.97% 18.84%
10 year 13.22% 8.06% 12.02%
15 year 8.27% 6.61% 9.14%
20 year 3.72% 3.60% n/a
Since Inception 5.61% n/a n/a
3 year risk 16.13 11.56 10.77
3 year beta n/a n/a 1.00
* Index refers to S&P 500 TR CAD

Top Holdings as of Dec 29, 2017
Apple Inc       9.80%
Microsoft Corp Ord       7.91%
Google Inc Cl A Ord       7.51%
Facebook Inc Ord       5.07%
Johnson & Johnson Ord       3.76%
Cash And Cash Equivalents       3.20%
Unitedhealth Group Inc Ord       2.78%
Visa Inc Ord       2.67%
Cisco Systems Inc Ord       2.45%
Pfizer Inc Ord       2.42%
Extras

Fund Report
Review and compare the current price and performance of all RBC Global Asset Management Inc.

Charting
Generate different performance charts for this Mutual Fund

PDF Fund Profile
Generate a full-color, print-ready profile in PDF format for this Mutual Fund

Fund Codes & Fees
View fund code, load type, trailer fee and fee schedule data for this Mutual Fund.

Fund Price History
View a 30-day price history for this fund


Investment Objectives
To provide long-term capital growth. The fund invests primarily in equity securities of U.S. companies whose businesses relate to life sciences and technology and are expected to benefit from scientific and technological advances.

Portfolio Composition
as of Dec 29, 2017

Sector Weightings
as of Dec 29, 2017

Stock 96.80% Information Technology 65.11%
Cash and Short Term Securities 3.20% Health Care 31.66%
Bond 0.00% Telecommunication Services 0.03%

Portfolio Manager(s)

Ray Mawhinney Manager
RBC Global Asset Management Inc.
Start Date: October, 2007
Fund Return: 10.85%
Ray graduated from the University of Manitoba with a Bachelor of Commerce degree in honours Finance and is a member of the Financial Analysts Federation. As Chair of the RBC Asset Management Inc. (RBC AM) U.S. Equity committee, Ray and his team of experts are responsible for managing the U.S. equity investment activities. Ray is also a member of our Equity Advisory Team.
Also manages: RBC U.S. Equity A, RBC U.S. Equity Cl A, RBC U.S. Equity Cl A USD, RBC U.S. Equity Cl Adv USD, RBC U.S. Equity Cl D USD, RBC U.S. Equity Cl O, RBC U.S. Equity Curr Neut O, RBC U.S. Equity F USD, RBC U.S. Equity O, RBC U.S. Equity O USD